Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 2,279,399 | 2,534,700 | 2,645,500 | 2,431,000 | 2,454,701 |
| Cost of Goods | 495,500 | 674,400 | 605,000 | 629,300 | 583,500 |
| Gross Profit | 1,783,900 | 1,860,300 | 2,040,500 | 1,801,700 | 1,871,200 |
| Operating Expenses | 1,686,000 | 1,269,300 | 1,247,800 | 1,422,400 | 1,430,300 |
| Operating Income | 98,400 | 591,400 | 792,700 | 379,600 | 441,401 |
| Other Income | -154,400 | -34,100 | -48,700 | -68,400 | -149,901 |
| Pre-tax Income | -56,000 | 557,300 | 744,000 | 311,200 | 291,500 |
| Income Tax | -7,100 | 90,800 | 109,200 | 70,700 | 24,800 |
| Net Income Continuous | -48,900 | 466,500 | 634,800 | 240,500 | 266,700 |
| Net Income | $-48,900 | $466,500 | $634,800 | $240,500 | $266,700 |
| EPS Basic Total Ops | -0.33 | 3.18 | 4.33 | 1.65 | 1.82 |
| EPS Basic Continuous Ops | -0.34 | 3.18 | 4.33 | 1.65 | 1.83 |
| EPS Diluted Total Ops | -0.35 | 3.17 | 4.33 | 1.64 | 1.82 |
| EPS Diluted Continuous Ops | -0.35 | 3.17 | 4.33 | 1.64 | 1.83 |
| EPS Diluted Before Non-Recurring Items | 1.99 | 4.81 | 5.47 | 3.02 | 3.44 |
| EBITDA(a) | $423,400 | $855,100 | $1,043,000 | $614,200 | $650,101 |